Shopping Cart
Remove All
Your shopping cart is currently empty
Apoptosis inducer39 is an apoptosis inducer with IC50 values of 4.53 μM for MDA-MB-231 cells and 15.42 μM for A549 cells. It exhibits antitumor activity in vitro by reducing the expression of the anti-apoptotic protein Bcl-2 and increasing the expression of the pro-apoptotic protein Bax. Apoptosis inducer39 is applicable in breast cancer and non-small cell lung cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Apoptosis inducer39 is an apoptosis inducer with IC50 values of 4.53 μM for MDA-MB-231 cells and 15.42 μM for A549 cells. It exhibits antitumor activity in vitro by reducing the expression of the anti-apoptotic protein Bcl-2 and increasing the expression of the pro-apoptotic protein Bax. Apoptosis inducer39 is applicable in breast cancer and non-small cell lung cancer research. |
| In vitro | Apoptosis inducer 39 (Compound Y22) (5-40 μM, 0-24 h) reduces the number of MDA-MB-231 cells, causing cell shrinkage and the formation of apoptotic blebs. Additionally, Apoptosis inducer 39 (5-20 μM, 24 h) significantly inhibits cell migration and exerts anti-tumor effects by inducing apoptosis in MDA-MB-231 cells. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.